TickerGuard
Buy Day today: Poor (52) Mixed market breadth · today: Core PCE (August) ≈
GLSI

Greenwich Lifesciences Inc

Healthcare · Biotechnology

18.10$ +3.4% vs. previous close Closing price · As of: Sep 24, 2026

Statements

Cash Flow

All figures per share in USD.

Tick rows to compare them in a chart (up to 4)

Cash Flow GLSI
Line item 2017 2018 2019 2020 2021 2022 2023 2024 2025
-0.01 -0.01 -0.02 -0.09 -0.33 -0.48 -0.50 -0.56 -0.73
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
– – 0.02 0.05 0.05 0.14 0.19 0.56 0.50
– 0.02 0.02 0.05 0.05 – – – –
0.12 0.13 0.25 0.00 -0.03 -0.01 0.00 0.10 0.20
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
-0.01 – – 2.37 0.24 -0.58 0.00 – –
– 0.01 0.02 -0.03 -0.02 – – – –
-0.01 0.02 0.02 2.35 0.22 -0.58 0.00 0.34 0.89
-0.02 0.01 -0.01 2.26 -0.11 -1.06 -0.50 -0.22 0.15
-0.01 -0.01 -0.02 -0.09 -0.33 -0.48 -0.50 -0.56 -0.73

Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?